Review of minimally invasive coronary artery bypass grafting

Allison J Walton1, Andres M Pineda2, Luke Rogers3,4

  • 1Division of Cardiothoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC, USA.

Insights

Minimally invasive coronary artery bypass grafting (CABG) offers a sternotomy-sparing approach for coronary artery disease (CAD). While uptake is slow, it shows promise for reduced complications and faster recovery in complex patients.

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Techniques
  • Coronary Artery Disease Management

Background:

  • Coronary artery bypass grafting (CABG) is a cornerstone treatment for coronary artery disease (CAD).
  • Traditional CABG involves a sternotomy, which carries potential risks and a longer recovery period.
  • Minimally invasive CABG (MICABG) offers an alternative approach, avoiding full sternotomy.

Purpose of the Study:

  • To provide an overview of minimally invasive CABG (MICABG) for clinicians managing patients with CAD.
  • To discuss the current status, techniques, and outcomes of MICABG.
  • To identify future directions and considerations for MICABG implementation.

Main Methods:

  • A narrative review of existing literature on minimally invasive CABG was conducted.
  • The review focused on techniques, patient selection, outcomes, and future prospects of MICABG.
  • Data from observational studies and randomized controlled trials were synthesized.

Main Results:

  • MICABG, particularly single-vessel procedures without cardiopulmonary bypass, has been available for over 20 years but has seen slow adoption.
  • Multivessel MICABG and hybrid revascularization (MICABG combined with percutaneous coronary intervention) are options for complex CAD.
  • Studies indicate MICABG is associated with lower transfusion rates, fewer infections, shorter ICU/hospital stays, and quicker return to activity.

Conclusions:

  • Minimally invasive CABG represents a valuable addition to the revascularization toolkit for an aging and complex CAD population.
  • Careful patient selection and preoperative planning are crucial for successful MICABG outcomes.
  • Further research and evidence are needed to fully elucidate the long-term benefits and expand the application of MICABG.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
510
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
298
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
411
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
728
Review and Preview01:10

Review and Preview

In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
8.4K